From the publishers of JADPRO
Metastatic HER2-Positive Breast Cancer
Resource Center
Menu
Resources
Videos
Videos
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Interview With Michelle Melisko, MD: Brain Metastases in HER2+ Breast Cancer
Last Updated: Wednesday, April 12, 2023
Advertisement
News & Literature Highlights
Nature Reviews Drug Discovery
Targeting HER2-positive breast cancer: advances and future directions
ESMO Congress 2022 Abstract
Final overall survival (OS) for abemaciclib plus trastuzumab +/- fulvestrant versus trastuzumab plus chemotherapy in patients with HR+, HER2+ advanced breast cancer (monarcHER): A randomized, open-label, phase II trial
ESMO Congress 2022 Abstract
Clinical safety and pharmacokinetics (PK) data of DZD1516, an BBB-penetrant selective HER2 inhibitor for the treatment of HER2-positive metastatic breast cancer
ESMO Congress 2022 Abstract
Quality of life and neurocognitive function in patients with active brain metastases of HER2-positive breast cancer treated with trastuzumab-deruxtecan
Cancer Network
Early efficacy observed with trastuzumab deruxtecan ± pertuzumab for HER2+ metastatic breast cancer
Oncology Nursing News
DESTINY-Breast02 confirms benefit of trastuzumab deruxtecan in previously treated patients with HER2+ metastatic breast cancer
Targeted Oncology
Safety of tucatinib triplet for HER2+ breast cancer sealed in real-world analysis
The ASCO Post
T-DXd confirmed as preferred second-line therapy for metastatic HER2-positive breast cancer
Clinical Breast Cancer
A phase II single-arm study of palbociclib in patients with HER2-positive breast cancer with brain metastases and analysis of ctDNA in patients with active brain metastases
Frontiers in Oncology
Treatment strategies for hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) metastatic breast cancer: A review
Advertisement
Case Studies
ERBB2 Mutation in HER2-Nonamplified Breast Cancer
Managing Cardiotoxicity Associated With HER2-Targeted Therapy
ER+/PR+ HER2+ Breast Cancer With Brain Metastases
Advertisement
Quizzes
Test your knowledge on managing cardiotoxicity associated with HER2-targeted therapy
Test your knowledge of brain metastases in the HER2+ breast cancer setting
Test your knowledge on second-line treatment and side-effect management in mHER2+ breast cancer